SammyJo Wilkinson was diagnosed with MS in 1995 and recently traveled to Mexico for Stem Cell Treatments. After years trying every FDA approved treatment in the U.S. she found a great alternative Stem Cell treatment in Houston, only to have the FDA require the clinic to get the treatment approved as a drug which was not feasible. The creators of the process ended up bringing their solution to the Mexican equivalent of the FDA who approved the procedure. Now patients travel to Cancun, Mexico to receive this life altering treatment. Part 1 of 2.
You should definitely check out the link in the resources for the Tisch MS Center’s Indigogo campaign that has successfully raised over $300,00 to fund FDA clinical trials of their new MS Stem cell therapy. What a great innovative way to fund medical research!
Thanks for listening. If you like the show, we would appreciate your comments and reviews
In This Episode, You’ll Learn
- How SammyJo was receiving stem cell treatment for her MS in Houston and why the FDA stopped allowing the procedure
- Why she selected Cancun, Mexico to continue her stem cell treatment
- Discover some of the other illnesses and diseases that stem cell therapy can help as SammyJo meets with many people on her trips
- How SammyJo and others are working hard on legislation called “Right to Try” that will enable terminal patients the ability to try more experimental treatments. Search the Twitter Hashtag #RightToTry
- Patients for Stem Cells
- Facebook Page of Patients for Stem Cells
- Business Week Article – Stem Cell Showdown: Celltex vs. the FDA
- Goldwater Institute
- Cleveland Clinic Stem Cell Therapy
- Tisch MS Center Indiegogo Fundraising Campaign
- Healthcare Elsewhere on Facebook
The Onwards Medical Breakthrough
Can the Nervous System Be Hacked?
“In September 2011, SetPoint Medical began the world’s first clinical trial to treat rheumatoid-arthritis patients with an implantable nerve stimulator based on Tracey’s discoveries. According to Ralph Zitnik, SetPoint’s chief medical officer, of the 18 patients currently enrolled in the ongoing trial, two-thirds have improved.”
You can learn more about this discovery at this link.